PIP4K2B and systemic sclerosis: Additional autoantibodies against anti-phosphatidylinositol-5-phosphate 4-kinase type 2 beta (PIP4K2B) and AKT serine/threonine kinase 3 (AKT3) have been linked to increased pulmonary fibrosis in SSc (114).